Name: UMIN ID:
Unique ID issued by UMIN | UMIN000014269 |
---|---|
Receipt number | R000016583 |
Scientific Title | Concurrent use of Sr-89 chloride with bone-modifying agent(denosumab, zoledronic acid) is safe and effective for breast cancer patients with painful bone metastases |
Date of disclosure of the study information | 2014/06/19 |
Last modified on | 2017/12/19 11:27:52 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/06/15 16:27:42 | ||
2 | Update | 2015/08/11 15:41:44 | UMIN ID1 |
|
3 | Update | 2017/12/19 11:27:52 | Recruitment status |